Kainate reveals its targets.
Lerma
J
J
Instituto Cajal, Consejo Superior de Investigaciones Cientifícas, Madrid, Spain.
D000818:Animals; D001921:Brain / Q000502:physiology*; D018698:Glutamic Acid / Q000502:physiology; D007608:Kainic Acid / Q000378:metabolism* / Q000494:pharmacology*; D008959:Models, Neurological; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D018091:Receptors, AMPA / Q000502:physiology; D018092:Kainic Acid Receptors / Q000502:physiology*; D016194:Receptors, N-Methyl-D-Aspartate / Q000502:physiology; D013569:Synapses / Q000502:physiology; D005680:gamma-Aminobutyric Acid / Q000502:physiology
D018698:Glutamic Acid; D007608:Kainic Acid; D018091:Receptors, AMPA; D018092:Kainic Acid Receptors; D016194:Receptors, N-Methyl-D-Aspartate; D005680:gamma-Aminobutyric Acid